{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-106664","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.247228+00:00","generated_at":"2026-05-17T00:13:14.065057+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ocugen Q3 net loss $20M; OCU400 Phase 3 nearing completion, Kwangdong deal signed","bullets":["Net loss of $20.0M ($0.07/sh) vs $13.0M ($0.05) in Q3 2024; cash $32.9M as of Sep 30 (down from $58.8M Dec 31).","OCU400 Phase 3 enrollment nearing completion; BLA filing target 1H 2026, top-line data expected 4Q 2026.","OCU410ST Phase 2/3 trial 50% enrolled; CHMP accepts single US trial for MAA; interim data mid-2026.","Signed licensing deal with Kwangdong for OCU400 in South Korea; up to $7.5M milestones plus sales milestones and 25% royalties.","Closed $20M registered direct offering; cash runway into Q2 2026; warrants exercise could add $30M and extend to 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-106664","json":"https://secwatch.observer/filing/0001104659-25-106664.json","markdown":"https://secwatch.observer/filing/0001104659-25-106664.md","text":"https://secwatch.observer/filing/0001104659-25-106664.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465925106664/0001104659-25-106664-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465925106664/tm2530208d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:13:14.065057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}